Mission

Be a global reference in deeptech solutions by AI-driven innovation, transforming research and development, regulatory compliance and drug discovery actions in new and safer therapies to the patients.

AI-Powered Pharma

Be a strategic AI partner for pharmaceutical and biotech companies

Vision

Values

People and Collaboration

Ethics and Responsability

Knowledge and Innovation

Our services

AI Integrity Solutions delivers specialized toxicology consulting for every stage of your pharmaceutical product's lifecycle. Our core services include complete non-clinical development support, thorough safety and risk evaluations (covering environmental factors, excipients, and impurities), and the accurate calculation of safety thresholds like PDEs and OELs. Our commitment is to guarantee your regulatory compliance worldwide, streamline your development process, and safely expedite your product's path to approval. Choose us for customized, science-driven solutions that fit your budget and needs

Nitrosamine Risk Assessment

Qualification of Non-Mutagenic Impurities

Potentially Mutagenic Impurities (PMIs)

Residual Solvents

Pharma Risk Assessment Services

Extractables & Leachables risk assessment

Qualification of Excipients

Elemental Impurities

In silico assessment

Permissible Daily Exposure (PDE) 

Health-Based Exposure Limits (HBELs) Services

Occupational Exposure Limits (OEL/OEB) 

Filling Data Gaps with Read-Across

Our products

Discover our suite of AI-driven software solutions, expertly designed to help you navigate regulatory compliance, manage critical risks, and accelerate innovation across the pharmaceutical, cosmetic, supplement, and food industries.

AI-Driven Industrial Pharmacoinformatics Solutions designed for compliance with FDA 21 CFR Part 11

Software solution providing end-to-end nitrosamine risk management for the Pharmaceutical, Cosmetic, Supplement, and Food industries

Software solution providing AI-driven mutagenicity and carcinogenicity assessment, boosted with RAx & expert review, ensuring ICH M7 & 21 CFR Part 11

Software solution providing AI-driven pKa and Ionization states, HPLC retention times, logP/D, solubility property prediction, boosted with hybrid Quantum Mechanical & AI models

Software solution providing a standardized, AI-driven approach for impurity risk assessment and ICH M7 purge factor calculations for API synthesis

Software solution providing generative AI & polypharmacology-driven molecular, biological signatures, creating multi-biological profiles, bridging chemistry and biology for drug discovery insights

Predict degradation products with Generative AI, grounded in reaction evidence, for ANVISA RDC 964/2025 & ICH compliant forced degradation studies

Multilingual executive with a distinguished career of over 40 years in the chemical and petrochemical industries. Renowned for visionary leadership in strategic planning, commercial management, and international business development. Held C-suite and board-level positions in major corporations across Brazil and Argentina, demonstrating a consistent record of driving growth, operational excellence, and market expansion. As Senior Vice President at Solvay S.A., in South America played a pivotal role in defining and executing the company’s strategic vision, championing innovation, and advancing corporate performance. Expert in mergers and acquisitions, customer relationship management, supply chain optimization, and corporate governance.

BSc, BA. Carlos A. Tieghi

Meet the team

Co-founder and CEO

Chemical Engineer

Dr. Rodolpho C. Braga

Co-founder and CTO

AI-driven drug discovery, Regulatory Expert

Leveraging over 15 years of computational modeling expertise, he spearheads the development of AI Integrity Solutions's Ecosystem software suite. It includes seven proprietary solutions for predictive toxicology and drug discovery, validated according to FDA 21 CFR Part 11 / GAMP5 guidelines to ensure suitability for use inside pharma companies. His technical leadership has propelled over 150 successful projects with major pharma clients, employing advanced techniques like Generative AI and atomic simulation

Paulo H. M. Palmeira

Head of Innovation R&D

Dr. Fabricio Vargas

Co-founder and COO

Process Optimization

Functioning as a Field Application Scientist and Regulatory Expert, he performs toxicological risk assessments during the pre-clinical and clinical development of drugs, cosmetics, environmental, and agricultural products. He also possesses experience in business management, securing public and private funds, and facilitating public-private Biotechnology partnerships within LATAM

Organic chemist with large experience as researcher and business management in the RD&I area at chemical and pharmaceutical industries. Vargas comes to AI Integrity Solutions as Head of Innovation to supervise the integration of AI Integrity Solutions's AI technology, foster innovation and ensure toxicological compliance for customers. Vargas will head an interdisciplinary group, support global projects, and boost corporate impacts. His inclusion promotes its aim to use AI to transform R&D and deliver innovative solutions for the industry